Musculoskeletal Progenitor/Stromal Cell-Derived Mitochondria Modulate Cell Differentiation and Therapeutical Function

Area of Science:

• Cellular Metabolism
• Immunology
• Stem Cell Biology

Background:

• Musculoskeletal stromal cells (MSCs) possess immunomodulatory properties crucial for tissue repair and immune homeostasis.
• MSC metabolism dynamically shifts, influencing their differentiation potential and immune regulatory functions.
• Understanding these metabolic adaptations is key to harnessing MSCs therapeutically.

Purpose of the Study:

• To review the intricate relationship between MSC metabolism and their immunomodulatory and differentiation capabilities.
• To elucidate the mechanisms by which MSCs transfer mitochondria (MT) to other cells.
• To explore the therapeutic potential of manipulating MSC metabolism for inflammatory diseases.

Main Methods:

• Literature review focusing on metabolic pathways in MSCs, including glycolysis and oxidative phosphorylation (OxPhos).
• Analysis of studies investigating MSC polarization and immune molecule production.
• Examination of research on mitochondria transfer mechanisms and their functional consequences.

Main Results:

• MSCs utilize glycolysis during proliferation and shift to OxPhos during osteogenic/adipogenic differentiation.
• Acquiring immunomodulatory properties induces a shift to aerobic glycolysis in MSCs.
• MSCs transfer functional mitochondria to injured cells, restoring cellular bioenergetics and homeostasis.

Conclusions:

• MSC metabolic plasticity is central to their differentiation and immune functions.
• Targeting MSC metabolism, especially mitochondria dynamics, presents a promising strategy for treating inflammatory conditions.
• Mitochondria transfer by MSCs represents a novel mechanism for intercellular communication and tissue repair.